Trials / Completed
CompletedNCT00143416
Long Term Study With B2036-PEG
Long-Term Study of B2036-PEG in Acromegaly - Long Term Study With B2036-PEG -
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 16 (planned)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective: To investigate the efficacy and safety of Pegvisomant in Japanese patients with acromegaly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pegvisomant |
Timeline
- Start date
- 2004-04-01
- Completion
- 2007-07-01
- First posted
- 2005-09-02
- Last updated
- 2008-07-29
Locations
8 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00143416. Inclusion in this directory is not an endorsement.